| [1] | Cresswell J.A., Alexander M., Chong M.Y.C., et al. (2025). Global and regional causes of maternal deaths 2009-20: A WHO systematic analysis. Lancet Glob. Health 13:e626−e634. DOI:10.1016/s2214-109x(24)00560-6 |
| [2] | Lissauer D., Gadama L., Waitt C., et al. (2025). A multicomponent intervention to improve maternal infection outcomes. N. Engl. J. Med. Advance online publication. DOI:10.1056/NEJMoa2512698 |
| [3] | Tita A.T.N., Carlo W.A., McClure E.M., et al. (2023). Azithromycin to prevent sepsis or death in women planning a vaginal birth. N. Engl. J. Med. 388:1161−1170. DOI:10.1056/NEJMoa2212111 |
| [4] | McClure E.M., Saleem S., Goudar S.S., et al. (2020). Stillbirth 2010-2018: A prospective, population-based, multi-country study from the Global Network. Reprod. Health 17:146. DOI:10.1186/s12978-020-00991-y |
| [5] | Qiao J., Wang Y., Li X., et al. (2021). A Lancet Commission on 70 years of women's reproductive, maternal, newborn, child, and adolescent health in China. Lancet 397:2497−2536. DOI:10.1016/s0140-6736(20)32708-2 |
| Chen Y., Chen D. and He F. (2026). From evidence to system-wide action: Adapting the APT-sepsis trial for China's maternal safety strategy. The Innovation Medicine 4:100218. https://doi.org/10.59717/j.xinn-med.2026.100218 |
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
A multicomponent intervention to improve maternal infection outcomes